Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy.
Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided Rapid Leukemia Subtype Inference), uses DNA methylation patterns and machine learning to classify acute leukemia with speed and accuracy
In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Central South University in China have developed an engineered strain of gut-homing bacteria that stimulates potent antitumor immune responses against colorectal cancer (CRC).
A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions.
The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year benefits from subthalamic nucleus deep brain stimulation for Parkinson’s disease. They find improved motor function and daily living activities with a 28% reduction in anti-Parkinson’s medication.
Techsomed this week announced it received FDA 510(k) clearance to expand indications for its BioTraceIO360 software platform to include percutaneous ablation of soft tissue in the kidney.
A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) has developed a highly detailed digital twin of the A549 lung cancer cell line. The twin builds on bioelectric processes and calcium dynamics in the cell interior in innovative new ways.
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights—including a model-estimated probability score for autism.
Researchers from the University of Birmingham’s Bladder Cancer Research Center have used a new method to detect chemical changes in the DNA in an individual’s urine sample; epigenetic changes, called methylation.
Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice and humans. In mice, a team led by Michael Kaminski was able to ease a key symptom of the difficult-to-treat disease.